-
Of 696 episodes of community-acquired meningitis in adults identified by the nationwide Dutch Meningitis Cohort study from 1998 to 2002, 30 (4%) were due to Listeria monocytogenes. The mean age was 65 ± 18 years; all 10 of the previously immunocompetent patients were >50 years of age.
-
Within the United States, 3 groups of individuals have been deemed the highest priority for annual influenza vaccination based on estimates of risk: (1) Persons ¡Ý 65 yrs; (2) Persons 18-64 yrs with chronic health conditions such as cardiorespiratory disease or who reside in a long-term care facility; (3) and health care workers and other persons with close contact with groups 1 and 2.
-
HIV antiretroviral therapy treatment soon will become a whole lot simpler than most antibiotic regimens when the FDA approves the combination pill of efavirenz/emtricitabine/ tenofovir (Truvada/Sustiva).
-
This article originally appeared in the August 2006 issue of Travel Medicine Advisor. It was edited by Frank Bia, MD, MPH, and peer reviewed by Philip R. Fischer, MD, DTM&H. Dr. Fishcer is Professor of Pediatrics, Divsion of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN. Dr. Fishcer reports no financial relationships relevant to this field of study.
-
The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance began collecting its data in 1994 on drug resistance in 90 countries.
-
-
The stroke and death rates at one and 6 months were lower in patients with symptomatic carotid stenosis (> 60%) treated with endarterectomy versus stenting.
-
A meta-analysis of 10 studies of heparin used either for prophylaxis or for treatment suggests that venous thromboembolism related to heparin-induced thrombocytopenia occurs frequently in patients previously treated with unfractionated heparin, but uncommonly in those on low molecular weight heparin.
-
Among adults diagnosed with heart failure who had no prior statin use, incident statin use was independently associated with lower risks of death and hospitalization among patients with or without coronary heart disease.
-
RFA should be considered a first-line therapy even after the first episode of symptomatic AFL. There is a better long-term success rate, the same risk of subsequent AF, and fewer secondary effects.
